Factor XIII Deficiency Presenting With Duodenal Hematoma in a 3‐Year‐Old Female: A Comprehensive Radiological Assessment Authors: Muhammad Khubaib Ullah, Faheemullah Khan, Muhammad Aman, Uffan Zafar, Muhammad Irfan, Kumail Khandwala, Naila Nadeem, Izaz Ahmad, Arsalan Nadeem, Noman Khan Published: 2024 ABSTRACT ABSTRACTIn the pediatric age group, FXIII deficiency can present as abnormal or delayed bleeding from the umbilical stump, soft tissue and subcutaneous bleeding, intracerebral hemorrhages, intraoral bleeding, and poor wound healing. This case report describes an atypical presentation of FXIII deficiency in a 3‐year‐old female who presented to the emergency department with complaints of abdominal pain and vomiting. She was managed conservatively under the care of the pediatric surgery team.Keywords: abdominal pain, duodenal hematoma, factor XIII deficiency, non‐surgical management, pediatric case, radiological assessment Summary Factor XIII (FXIII) deficiency, though rare, should be considered in pediatric patients with unexplained abdominal pain, vomiting, anemia, and abnormal clotting. Factor XIII (FXIII) deficiency, though rare, should be considered in pediatric patients with unexplained abdominal pain, vomiting, anemia, and abnormal clotting. Prompt diagnosis enables non‐surgical management with FXIII replacement, mitigating potential complications. Prompt diagnosis enables non‐surgical management with FXIII replacement, mitigating potential complications. Clinicians must include this condition in the differential diagnosis for effective patient care. Clinicians must include this condition in the differential diagnosis for effective patient care. Introduction Factor XIII (FXIII) deficiency is an autosomal recessive disorder characterized by a deficiency in FXIII, the final enzyme in the clotting pathway. FXIII is responsible for catalyzing the cross‐linking between fibrin molecules, converting the fibrin polymer into a stable, organized, cross‐linked structure that is relatively resistant to fibrinolysis [1, 2, 3, 4, 5]. In the pediatric age group, this deficiency can manifest as abnormal bleeding from the umbilical stump, soft tissue and subcutaneous bleeding, intracerebral hemorrhages, intraoral bleeding, and poor wound healing. This case report details a unique presentation of FXIII deficiency at our hospital, which was ultimately diagnosed as a large duodenal hematoma [2]. Duodenal hematomas are themselves rare, mostly caused by blunt abdominal trauma. Less frequently, they are associated with bleeding disorders, as in this case, or complications of anticoagulation therapy or endoscopy [6, 7, 8, 9]. We present the case of a 3‐year‐old female who presented to the emergency room (ER) with abdominal pain and vomiting. This case report outlines the clinical presentation, radiological findings, and non‐surgical management of the patient. Case History and Examination A 3‐year‐old girl presented to our hospital with complaints of gradual abdominal pain and non‐bilious vomiting that progressed over 2 days. Upon examination, the patient was irritable yet active, and vitally stable. There was no associated fever, diarrhea, or dysuria, and the child had been tolerating oral intake poorly since the onset of symptoms. The vitals included a heart rate of 98 beats/min, respiratory rate of 22 breaths/min, blood pressure of 90/65 mmHg, and oxygen saturation of 99% on room air. She was afebrile. Cardiovascular examination was normal with a regular heart rate and rhythm, no murmurs, and good peripheral pulses. Respiratory examination revealed normal breath sounds bilaterally, with no wheezing, crackles, or signs of respiratory distress. The patient had no significant past medical history, with no prior hospitalizations, surgeries, or similar episodes of abdominal discomfort. Birth history was unremarkable, with a full‐term normal delivery and no complications reported during the neonatal period. Family history was negative for any known bleeding disorders, gastrointestinal conditions, or coagulation abnormalities. The child had no such previous episodes similar to this. Methods (Differential Diagnosis, Investigations, and Treatment) Laboratory investigations (Table 1) revealed decreased hemoglobin (Hb), leukocytosis, decreased mean corpuscular volume (MCV), low red blood cell (RBC) count, and platelets at the lower limit. The prothrombin time (PT) and activated partial thromboplastin time (aPTT) were within the normal range. TABLE 1Results of the laboratory investigations.InvestigationResultNormal rangeHemoglobin (Hb) 7.3 g/dL 11.5–17.5 g/dLLeukocyte count 16.1 × 109/L 5.0–15.0 × 109/LMean corpuscular volume (MCV) 72.4 fL 76–96 fLRed blood cell (RBC) count 3.69 × 106/μL 4–6 × 106/μLPlatelets150 × 109/L150–400 × 109/LProthrombin time (PT)12.7 s11–15 sActivated partial thromboplastin time (aPTT)27 s25–40 sFactor XIII 62% 70%–140%Bleeding time2 min1–10 minBlood urea nitrogen (BUN)17 mg/dL6–20 mg/dLCreatinine0.3 mg/dL0.3–0.7 mg/dLTotal bilirubin1.1 mg/dL0.1–1.2 mg/dLDirect bilirubin 0.4 mg/dL 0–0.2 mg/dLIndirect bilirubin0.7 mg/dL0.1–0.8 mg/dLGamma‐glutamyl transferase (GGT)4 U/L0–45 U/LAlanine aminotransferase (SGPT/ALT)12 U/L7–56 U/LAspartate aminotransferase (SGOT/AST)337 U/L54–369 U/LC‐reactive protein (CRP)43 U/L8–33 U/LAlkaline phosphatase (AP)4.85 mg/dL0–14 mg/dL Results of the laboratory investigations. An abdominal X‐ray was not performed at the time of presentation, as the patient's clinical examination, which showed a soft and non‐tender abdomen, absence of bowel obstruction signs, and normal bowel sounds, did not raise immediate concern for conditions typically requiring radiographic evaluation, such as bowel perforation or obstruction. Additionally, plain X‐rays have limited utility in detecting soft tissue abnormalities like a duodenal hematoma, which are better visualized using ultrasound or computed tomography (CT) scans. Given the patient's condition and the clinical findings, further imaging modalities were prioritized over an X‐ray. The pediatric surgical team initially suspected intussusception and performed an ultrasound, which did not show signs of intussusception but revealed a rounded hypo to iso‐echoic lobulated area adjacent to the porta hepatis and head of the pancreas, devoid of vascularity. Further evaluation with cross‐sectional imaging was recommended, leading to a CT scan of the abdomen with contrast. The CT abdomen with contrast revealed a large intramural/submucosal duodenal hematoma along its entire length, causing luminal narrowing (Figure 1). (A) Axial CECT demonstrates a large duodenal intramural hematoma obliterating the duodenal lumen (arrow indicates the intramural hematoma, arrowhead depicts the duodenal lumen). (B) Coronal image reveals the hematoma running along the duodenal wall, causing luminal narrowing (depicted by orange lines, while arrows identify the long segment intramural duodenal hematoma). The radiology team suggested an additional workup to rule out underlying hematological disorders or myeloproliferative diseases. Given the spontaneous nature of the duodenal hematoma, without a history of trauma or significant medical history, a coagulation disorder was suspected. Initial investigations, including PT, aPTT, and bleeding time, were all within normal limits, ruling out more common coagulation disorders. The persistence of the hematoma without a clear etiology led the clinical team to consider rarer coagulation factor deficiencies. Among these, FXIII deficiency was suspected, which often presents with normal routine coagulation tests, particularly a normal PT and aPTT. This prompted specific testing for FXIII. The coagulation profile showed a deficiency of FXIII (Table 1), which was determined to be the cause of the duodenal hematoma. Acquired causes of FXIII deficiency, such as liver disease, malignancy, or autoimmune conditions, were considered. The patient had no history of liver dysfunction, and the liver function tests were within normal limits, effectively ruling out liver disease as a potential cause. Additionally, there were no clinical or laboratory signs of malignancy or systemic autoimmune conditions, such as normal blood counts, absence of lymphadenopathy or splenomegaly, and no abnormal findings in autoimmune screens, including ANA and RF. Other differential diagnoses, including platelet dysfunction and von Willebrand disease, were ruled out based on a normal platelet count and von Willebrand factor antigen levels. Imaging and clinical findings also ruled out trauma or mechanical causes of the hematoma. Considering all of this information, congenital FXIII deficiency was adopted as the working diagnosis. An esophagogram demonstrated a thin streak of contrast trickling into the proximal duodenum, suggestive of near‐complete proximal duodenal obstruction (Figure 2). The patient was subsequently advised non‐surgical management. Initially, she was kept nil per oral (NPO) and received intravenous hydration. A peripherally placed central venous catheter was placed under sedation after obtaining consent from the parents, and total parenteral nutrition (TPN) was initiated. The care plan was explained to the family, and the patient's hemodynamic parameters and output were closely monitored. Once stable, clear fluids were introduced, which the patient tolerated well. In the emergency room, normal saline and 5% dextrose saline 0.9% were administered to maintain hydration and electrolyte balance. Antibiotics administered included amoxicillin + clavulanic acid and metronidazole to combat potential infections, with amikacin sulfate also given as part of the antibiotic therapy. Omeprazole was administered intravenously to manage gastric acid levels, likely to prevent stress ulcers in the critical care setting, and paracetamol was provided to manage fever or pain. The medications were provided on a STAT basis due to the urgency of the patient's condition. Fluoroscopic image, oral contrast outlining the stomach (arrow), streak of contrast is trickling down the duodenum outlining its narrowed lumen (arrow heads). Conclusion and Results (Outcome and Follow‐Up) Upon request, the patient was discharged in a vitally stable condition with home care instructions, including dietary adjustments and precautions to avoid activities that might strain the abdomen. The family was instructed to monitor for any signs of recurrent abdominal pain, vomiting, or bleeding. A follow‐up appointment 2 weeks later with the pediatric surgeon and the hematologist showed no remarkable findings, and the patient remained asymptomatic. Regular follow‐up with a hematologist was planned to monitor for any future bleeding episodes, with consideration of FXIII replacement therapy if needed. Discussion FXIII (also known as fibrin stabilizing factor) deficiency is one of the rarest factor deficiencies, occurring in approximately 1 in every 2 million people worldwide. Its function includes stabilizing blood clot formation, aiding in tissue repair, depositing extracellular matrix, and contributing to the differentiation of osteoblasts [2]. The deficiency typically presents as excessive and prolonged bleeding from the umbilical stump, poor wound healing, and can lead to complications such as intracranial hemorrhage, either spontaneously or post‐traumatically [10]. Additionally, superficial and deep hematomas are associated with the deficiency, although they are more commonly observed in older age groups [11]. Diagnosing FXIII deficiency can be challenging, as standard clotting tests such as PT, aPTT, and INR are usually normal. Key laboratory investigations for diagnosis include the clot solubility test, FXIII activity assay, FXIII antigen assay, inhibitor assay, and molecular diagnostics [2]. In this case, the clot solubility test was not performed due to the availability of more specific and direct tests, such as the FXIII activity assay, which confirmed the diagnosis. This case is unique because we believe it is the first reported instance of a duodenal hematoma due to FXIII deficiency. Duodenal hematomas are typically caused by crushing blunt force that ruptures intramural blood vessels or as a complication of anticoagulant therapy, endoscopic biopsy, vasculitis, pancreatitis, tumors, or bleeding disorders [6, 7, 8, 9]. Early diagnosis of FXIII deficiency allows for conservative treatment, avoiding surgery [6, 8, 9, 12, 13]. Treatment options for FXIII deficiency include fresh frozen plasma (FFP) or cryoprecipitate. However, with advancements, FXIII concentrate and recombinant FXIII (rFXIII) are available for severe deficiencies to reduce bleeding events. For duodenal hematomas, treatment can be conservative or invasive. Conservative management involves keeping the patient NPO for bowel rest and nasogastric (NG) decompression, placing a peripherally inserted central catheter (PICC), and initiating parenteral nutrition [14, 15, 16, 17]. The duration of conservative management varies, and enteral nutrition can begin once gastric aspirates are no longer bilious. Surgical treatment options include hematoma removal or bypass surgery [18]. In the past, when radiological advancements were not available, an exploratory laparotomy was performed after blunt abdominal trauma for evacuation, but this is now an option primarily in cases of jaundice and delayed bowel obstruction [19]. Invasive surgical procedures may still be necessary for complications such as uncontrolled bleeding or panperitonitis [20]. Recent advances include endoscopic drainage with fistula formation or mucosal puncture, which has shown success without major complications [21]. In cases of intramural duodenal hematomas (IMDH), percutaneous catheter insertion can be used for decompression [22]. Conclusion This case highlights the importance of swift clinical observation, thorough evaluation, and comprehensive radiological assessment in the management of duodenal hematoma, particularly in the pediatric age group. Medical practitioners should be vigilant of this rare condition and include it in their differential diagnosis for patients presenting with abdominal pain and vomiting, particularly those with a history of bleeding disorders. Early recognition and diagnosis can lead to timely and appropriate management, potentially avoiding complications and unnecessary surgical interventions. It is crucial to consider rare coagulation disorders, such as FXIII deficiency, when routine tests are inconclusive, to ensure timely diagnosis and treatment. Author Contributions Muhammad Khubaib Ullah: data curation, writing – original draft, writing – review and editing. Faheemullah Khan: data curation, writing – original draft, writing – review and editing. Muhammad Aman: writing – original draft, writing – review and editing. Uffan Zafar: writing – original draft, writing – review and editing. Muhammad Irfan: writing – original draft, writing – review and editing. Kumail Khandwala: supervision, writing – review and editing. Naila Nadeem: supervision, writing – review and editing. Izaz Ahmad: supervision, writing – review and editing. Arsalan Nadeem: writing – review and editing. Noman Khan: supervision, writing – review and editing. Consent Written informed consent was obtained from the patient to publish this report in accordance with the journal's patient consent policy. Conflicts of Interest The authors declare no conflicts of interest. Acknowledgments The authors have nothing to report. Funding: The authors received no specific funding for this work. Data Availability Statement Data sharing is not applicable to this article as no new data were created or analyzed in this study. References Associated Data Data Availability Statement Data sharing is not applicable to this article as no new data were created or analyzed in this study.